FDA: Alerts health care providers and patients about increased risk of new blood cancers with Tazverik (tazemetostat) use May 11, 2026 01:21PM
BNP Paribas Exane Downgrades Ipsen SA (IPN:FP) (IPSEY) to Underperform Dec 10, 2025 03:52AM
Ipsen presents long-term IQIRVO data at liver disease conference Nov 7, 2025 08:50AM
Ipsen wins EU approval for Cabometyx in neuroendocrine tumors Jul 24, 2025 01:42PM
Deutsche Bank Upgrades Ipsen SA (IPN:FP) (IPSEY) to Buy Apr 2, 2025 03:54AM